Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Inetetamab|DRUG: Pyrotinib|DRUG: Capecitabine|DRUG: Gemcitabine|DRUG: Vinorelbine|DRUG: Carboplatin|DRUG: Albumin paclitaxel|DRUG: Eribulin
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University